Judith M. Bliss

Also affiliated with Cancer Research UK, Trinity College London, Institute of Cancer Research, Cancer Research UK Clinical Trials Unit, CRUK Lung Cancer Centre of Excellence

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial”.

Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101435

N/A

0.457DataRank · unranked

20 citations

Richard Marais, Núria Porta, David González de Castro, Lisa Parsons, Christina Messiou +18 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159

N/A

0DataRank · unranked

450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00452-8

N/A

0DataRank · unranked

13 citations

Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer +15 more

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1 -Mutant Breast Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1387

N/A

0DataRank · unranked

38 citations

Alex Pearson, María Teresa Herrera-Abreu, Li-Xuan Sim, Rosalind Cutts, Heena Shah +12 more

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

ESMO Open(2024)10.1016/j.esmoop.2024.103938

N/A

0DataRank · unranked

9 citations

M. Piccart-Gebhart, Shona Fielding, John Townend, D.W. Hillman, M. Colleoni +37 more

What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials

BMJ Open(2024)10.1136/bmjopen-2024-088600

N/A

0DataRank · unranked

13 citations

Fiona Adshead, Rustam Al‐Shahi Salman, Craig S. Anderson, Emma Bedson, Judith M. Bliss +25 more